Mu gihe duhanganye n'ikibazo cyo kuvura kanseri y'inkondo y'umura ya HER2, turasobanukiwe neza icyifuzo cyawe cyihutirwa cyo kuvura neza kandi mu buryo bugezweho. Uyu munsi, tuzana amakuru akomeye atera inkunga aturutse mu rwego rw'ubuvuzi bwa kanseri mu Bushinwa.
**Ubuvuzi Bugezweho Burashoboka: SHR-A1811 Igaragaza Ubushobozi Budasanzwe**
Ku ya 28 Mutarama 2025, Ikigo cy’Isuzuma ry’Imiti (CDE) cy’Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa cyatangaje ko SHR-A1811, umuti ugezweho uhuza imiti irwanya indwara (ADC) wakozwe ku giti cya Hengrui Pharma, uteganyijwe gusuzumwa mbere na mbere. Ugenewe kuvura abarwayi bakuru barwaye kanseri y’inkondo y’umura ya HER2 bananiwe kuvurwa mbere hakoreshejwe oxaliplatin, fluorouracil, na irinotecan. Ibi bigaragaza intambwe ikomeye mu ikoreshwa ryayo mu kuvura kanseri y’inkondo y’umura, bitanga icyizere gishya ku barwayi barangije uburyo busanzwe bwo kuvura.

Nyuma yo kugaragaza ko uyu muti wemewe mu Bushinwa muri Gicurasi 2025 ku ndwara ya kanseri y'ibihaha idahinduka ya HER2-mutant, uba umuti wa mbere wa ADC wakorewe mu Bushinwa ku giti cye wemewe muri urwo rwego. Ubu, amakuru yawo ku ndwara ya kanseri y'inkondo y'umura aratanga icyizere: nk'uko byagaragajwe n'ibyavuye mu igerageza ryakozwe mu cyiciro cya mbere cyatanzwe mu nama y'Umuryango w'Uburayi wita ku ndwara ya kanseri y'inkondo y'umura (ESMO), ku gipimo cyagenwe, igipimo cyo kwitabwaho (ORR) cyageze kuri 46.9%, naho igipimo cyo kubaho mu mezi 6 nta ndwara cyari hejuru ya 85.5% ku barwayi ba kanseri y'inkondo y'umura ya HER2-positive. Aya makuru agaragaza ko hari amahirwe menshi yo kunoza ubuzima ku barwayi ba kanseri y'inkondo y'umura ya HER2-positive.
**Kuki wahitamo Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo ka Beijing?**
Mu gihe ikoranabuhanga ry’ubuvuzi rikomeje gutera imbere mu Bushinwa, uburyo bwo kubona ubu buryo bugezweho mu mutekano, vuba kandi neza ni ikibazo cy’ingenzi ku barwayi mpuzamahanga. Ishami Mpuzamahanga ry’Ibitaro bya Oncology bya Beijing mu Karere k’Amajyepfo ryashinzwe kubera iyi mpamvu:
1. **Inzira yihuse yo kuvura mu buryo buhanitse:** Dukurikirana byimbitse ibijyanye n’imiti igezweho n’ubushakashatsi mu buvuzi mu Bushinwa. Dushobora gusuzuma no guha abarwayi mpuzamahanga bujuje ibisabwa uburyo bwo kuvura mu buryo buhanitse.
2. **Serivisi Mpuzamahanga zijyanye n'Ubuvuzi:** Kuva ku bujyanama bw'abaganga b'inzobere no guhindura no gusuzuma inyandiko z'ubuvuzi mu ndimi ebyiri (Igishinwa n'Icyongereza) kugeza ku gutunganya neza amabaruwa y'ubutumire bwa viza, hagakurikiraho "guherekeza umuntu umwe" mu gihe cyo kwakirwa mu bitaro, ubufasha mu buzima bwa buri munsi, no gukurikirana nyuma yo kuva mu bitaro, dutanga serivisi zirambuye kandi zihariye kugira ngo urugendo rw'ubuvuzi mu Bushinwa rugende neza kandi rudafite impungenge.
3. **Itsinda ry’abaganga bo mu rwego rwo hejuru n’ibidukikije:** Ibitaro bihuriza hamwe impuguke zizwi mu buvuzi bwa kanseri ziturutse hirya no hino mu Bushinwa, zifite ikoranabuhanga rigezweho ryo gusuzuma no kuvura. Dutanga kandi ibitaro mpuzamahanga biruhura abarwayi ndetse n’ahantu ho kuvura abarwayi, tugakora ibishoboka byose kugira ngo ubuvuzi buhabwe ubuvuzi bwiza kandi bugaragare neza.
**Twandikire ubu kugira ngo utangire urugendo rwawe rw'ibyiringiro**
Dusobanukiwe akamaro gakomeye k'igihe mu kuvura kanseri. Niba wowe cyangwa uwo ukunda muhanganye na kanseri y'inkondo y'umura ya HER2 cyangwa izindi mbogamizi za kanseri kandi mukaba mwifuza kumenya byinshi kuri SHR-A1811 cyangwa ubundi buryo bushya bwo kuvura, nyamuneka ntutindiganye kuduhamagara vuba ukoresheje uburyo ubu n'ubu bukurikira:
- Umurongo wa telefoni ufasha abantu gutanga serivisi: 400-880-3716
**Ubundi buryo bworoshye bwo gushyikirana:**
- **WeChat:** Ongeramo indangamuntu `17801183037`. Abahuzabikorwa bacu b'ubuvuzi bazatanga ubufasha bwihuse bwo gutumanaho kuri interineti.
- **Imeri:**
- 100085_010@163.com
- myimmnet@163.com
Ushobora kohereza incamake y'ubuvuzi bwawe n'ibizamini bireba kuri aderesi za imeri zavuzwe haruguru, maze tuzategura isuzuma ry'ibanze ry'impuguke.
Iterambere ryose ry’ikoranabuhanga rizana icyizere gishya ku buzima butagira ingano. Ishami Mpuzamahanga ry’Ibitaro Mpuzamahanga bya Oncology bya Beijing mu Karere k’Amajyepfo ryiyemeje kuba umufatanyabikorwa wawe wizeye mu kurwanya indwara, ritanga ubumenyi bw’umwuga mu buvuzi na serivisi mpuzamahanga zishyushye.
**Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo muri Beijing: Kugendana n’Isi, Kurinda Ubuzima.**
Igihe cyo kohereza: Mutarama-29-2026
